APA

Cohen J. A., Khatri B., Barkhof F., Comi G., Hartung H., Montalban X., Pelletier J., Stites T., Ritter S., von Rosenstiel P., Tomic D. & Kappos L. (20160829). Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study. : Journal of neurology, neurosurgery, and psychiatry.

Chicago

Cohen Jeffrey A, Khatri Bhupendra, Barkhof Frederik, Comi Giancarlo, Hartung Hans-Peter, Montalban Xavier, Pelletier Jean, Stites Tracy, Ritter Shannon, von Rosenstiel Philipp, Tomic Davorka and Kappos Ludwig. 20160829. Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study. : Journal of neurology, neurosurgery, and psychiatry.

Harvard

Cohen J. A., Khatri B., Barkhof F., Comi G., Hartung H., Montalban X., Pelletier J., Stites T., Ritter S., von Rosenstiel P., Tomic D. and Kappos L. (20160829). Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study. : Journal of neurology, neurosurgery, and psychiatry.

MLA

Cohen Jeffrey A, Khatri Bhupendra, Barkhof Frederik, Comi Giancarlo, Hartung Hans-Peter, Montalban Xavier, Pelletier Jean, Stites Tracy, Ritter Shannon, von Rosenstiel Philipp, Tomic Davorka and Kappos Ludwig. Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study. : Journal of neurology, neurosurgery, and psychiatry. 20160829.